Study Finds Three Brain Biotypes in Youth ADHD
Stanford Medicine-led researchers used AI-powered brain scan analysis to group children with ADHD or anxiety into three distinct biotypes.
Updated on Nov. 13, 2026 in Autism

A Stanford Medicine-led study published in Nature Mental Health identified three brain biotypes in children with ADHD or anxiety disorder. The research analyzed brain scans from the Adolescent Brain Cognitive Development study, which includes more than 11,000 U.S. children.
Why it matters
The findings suggest that ADHD and anxiety may not be uniform conditions, which could help match children with treatments suited to their specific brain patterns. Researchers also hope the biotypes can serve as early indicators to enable more timely intervention.
The study used brain scans and behavioral assessments from a cohort of children aged 9 or 10 at enrollment, comparing 3,508 children with ADHD or anxiety against 1,947 controls. Whether the biotypes will translate into clinical treatment guidance remains untested.
The players
Stanford Medicine
Stanford Medicine is the academic medical center of Stanford University in California, known for its biomedical research and clinical care programs.
Yu Zhang
Yu Zhang is the lead researcher on the Stanford Medicine-led study who envisions using the biotypes to match children to treatments in future clinical trials.
The details
Researchers built an AI-powered model to analyze functional connectivity on children's brain scans, incorporating diagnoses and behavioral assessments. The model identified two brain-behavior dimensions, cognitive-behavioral dysfunction and emotion-attention dysfunction, and grouped children into three biotypes: externalizing-disinhibited, internalizing-distressed and mixed.
Timeline
Children in the Adolescent Brain Cognitive Development study were enrolled at ages 9 or 10.
Study results were published on November 13, 2026.
Big Picture
The study builds on the Adolescent Brain Cognitive Development study, a longitudinal brain imaging project of more than 11,000 U.S. children, by moving beyond diagnostic categories to identify neurobiological subgroups. It suggests ADHD and anxiety may be better understood through brain connectivity patterns than through symptom-based labels alone.
Parents of children diagnosed with ADHD or anxiety may eventually benefit from treatments matched to their child's brain biotype rather than diagnosis alone. Current clinical care is not yet changed by these findings, and the biotypes have not been validated as treatment guides.
The takeaway
Diagnostic labels like ADHD and anxiety may mask distinct underlying brain patterns, so future care could rely more on biology than on symptoms alone. Families should continue working with clinicians on current evidence-based treatments while such research is still developing.
Further reading
Explore related coverage in the Autism section for more context on neurodevelopmental research.










